Zenas BioPharma
(NASDAQ) ZBIO
Zenas BioPharma Financials at a Glance
Market Cap
$1.34B
Revenue (TTM)
$10.00M
Net Income (TTM)
$377.74M
EPS (TTM)
$-8.44
P/E Ratio
-2.77
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$21.90
Volume
31,541
Open
$23.68
Price
$21.90
Volume
31,541
Open
$23.68
Previous Close
$21.90
Daily Range
$21.32 - $24.00
52-Week Range
$6.11 - $44.60
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$21.90
Volume
31,541
Open
$23.68
Previous Close
$21.90
Daily Range
$21.32 - $24.00
52-Week Range
$6.11 - $44.60
ZBIO News
ZBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zenas BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
167
CEO
Lonnie Moulder, Jr., MBA
Website
www.zenasbio.comHeadquarters
Waltham, MA 02451, US
ZBIO Financials
Key Financial Metrics (TTM)
Gross Margin
-4%
Operating Margin
-22%
Net Income Margin
-38%
Return on Equity
-136%
Return on Capital
-67%
Return on Assets
-98%
Earnings Yield
-36.10%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.34B
Shares Outstanding
57.36M
Volume
31.54K
Short Interest
0.00%
Avg. Volume
841.70K
Financials (TTM)
Gross Profit
$9.94M
Operating Income
$211.38M
EBITDA
$211.33M
Operating Cash Flow
$172.33M
Capital Expenditure
$18.00K
Free Cash Flow
$172.35M
Cash & ST Invst.
$343.19M
Total Debt
$79.96M
Zenas BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$10.00K
-100.2%
Gross Margin
0.00%
N/A
Market Cap
$1.34B
N/A
Market Cap/Employee
$10.31M
N/A
Employees
130
N/A
Net Income
$240.44M
-357.1%
EBITDA
$71.30M
-28.3%
Quarterly Fundamentals
Net Cash
$341.87M
-2.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$78.85M
+36068.3%
Short Term Debt
$1.11M
+42.0%
Return on Assets
-98.46%
N/A
Return on Invested Capital
-67.41%
N/A
Free Cash Flow
$52.41M
-35.7%
Operating Cash Flow
$52.41M
-35.9%